ArticleBone marrow transplantation2023

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).

Eleni Gavriilaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.